Moreover, ROC curve analysis showed that low p62 at admission was able to discriminate COVID-19 patients from healthy controls with 89% sensitivity and 95% specificity at the cut-off level of 2.14 ng/mL, performing better than high cytokine levels in that respect (Supplementary Figure S7). This evidence concerns the gene SQSTM1 and COVID-19.